Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2525-2531

  Reed, Melissa A ^a   Pories, Walter J ^b   Chapman, William ^b   Pender, John ^b   Bowden, Rita ^b   Barakat, Hisham ^b   Gavin, Timothy P ^a   Green, Tom ^b   Tapscott, Ed ^b   Zheng, Donghai ^a,b   Shankley, Nigel ^c   Yieh, Lynn ^c   Polidori, David ^c   Piccoli, Steven P ^c   Brenner Gati, Leona ^d   Dohm, G Lynis ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REMISSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SURGICAL PATIENT; TREATMENT RESPONSE; UNITED STATES;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OBESITY, MORBID; REMISSION INDUCTION;

EID: 79961238549     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0165     Document Type: Article

References (20)

1. Pories WJ, MacDonald Jr KG, Flickinger EG, Dohm GL, Sinha MK, Barakat HA, May HJ, Khazanie P, Swanson MS, Morgan E, Leggett-Frazier N, Long SD, Brown BM, O'Brien K, Caro JF 1992 Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg 215:633-642; discussion 643
2. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248-256.e5
3. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, de Ramon RA, Israel G, Dolezal JM, Dohm GL 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-350; discussion 350-332
4. Pories WJ, MacDonald Jr KG, Morgan EJ, Sinha MK, Dohm GL, Swanson MS, Barakat HA, Khazanie PG, Leggett-Frazier N, Long SD, O'Brien KF, Caro JF 1992 Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55:582S-585S
5. Bikman BT, Zheng D, Pories WJ, Chapman W, Pender JR, Bowden RC, Reed MA, Cortright RN, Tapscott EB, Houmard JA, Tanner CJ, Lee J, Dohm GL 2008 Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab 93:4656-4663
6. MacDonald KG, Jr., Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ 1997 The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213-220; discussion 220
7. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93:2479-2485 (Pubitemid 352008510)
8. Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR 2010 Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 34:462-471
9. DeFronzo RA 2004 Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787-835, ix
10. Mari A, Tura A, Gastaldelli A, Ferrannini E 2002 Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221-S226 (Pubitemid 34761519)
11. Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE, Deacon CF, Holst JJ, Foley JE 2005 Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed β-cell function in patients with type 2 diabetes. J Clin Endocrinol Metab 90:4888-4894 (Pubitemid 41159387)
12. Mari A, Degn K, Brock B, Rungby J, Ferrannini E, Schmitz O 2007 Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on β-cell function in normal living conditions. Diabetes Care 30:2032-2033 (Pubitemid 47219415)
13. Van Cauter E, Mestrez F, Sturis J, Polonsky KS 1992 Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
14. Bergman RN, Finegood DT, Ader M 1985 Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86
15. Pories WJ 1992 Why does the gastric bypass control type 2 diabetes mellitus? Obes Surg 2:303-313
16. Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G 2009 First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 32:375-380
17. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G 2006 Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025-2031 (Pubitemid 44509976)
18. Dankner R, Chetrit A, Shanik MH, Raz I, Roth J 2009 Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 32:1464-1466
19. Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL 2000 Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49:1353-1358 (Pubitemid 30624237)
20. Zhou Q, Dolan PL, Dohm GL 1999 Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats. Mol Cell Biochem 194:209-216 (Pubitemid 29245561)